San Clemente, CA – September 29, 2025 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER…
Read More
Spur® Peripheral Retrievable Stent System Receives FDA De NovoClearance We’re proud to announce that our first-of-its-kind Spur Stent System is now commercially available in the U.S. Featuring innovative Spur technology,…
In the past 12 months, we’ve signed 25 new distribution agreements with strong, strategic partners located outside of the U.S. who understand our mission and are ready to amplify it….
Recent Comments